Found 5 matching trials
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma PHASE1 This is a two-arm, open-label, phase Ib single-site study with expansion co...
Show More Status
Active Not Recruiting
Location
Washington University School of Medicine
Learn More & Join Trial
Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial PHASE2 This is a prospective, open-label, single-arm, umbrella phase 2 clinical tr...
Show More Location
Multiple Locations
Learn More & Join Trial
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma PHASE1 The aim of this study was to analyze the safety and efficacy of CD3-CD20 bi...
Show More Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Learn More & Join Trial